Literature DB >> 16758178

Hypoglycaemia: the limiting factor in the glycaemic management of the critically ill?

P E Cryer1.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16758178     DOI: 10.1007/s00125-006-0306-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  15 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

Review 2.  Diverse causes of hypoglycemia-associated autonomic failure in diabetes.

Authors:  Philip E Cryer
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

Review 3.  Tight blood glucose control with insulin in "real-life" intensive care.

Authors:  Greet Van den Berghe
Journal:  Mayo Clin Proc       Date:  2004-08       Impact factor: 7.616

4.  Glycemic control in the intensive care unit: why we should wait for NICE-SUGAR.

Authors:  Rinaldo Bellomo; Moritoki Egi
Journal:  Mayo Clin Proc       Date:  2005-12       Impact factor: 7.616

5.  Intensive insulin therapy in the medical ICU.

Authors:  Greet Van den Berghe; Alexander Wilmer; Greet Hermans; Wouter Meersseman; Pieter J Wouters; Ilse Milants; Eric Van Wijngaerden; Herman Bobbaers; Roger Bouillon
Journal:  N Engl J Med       Date:  2006-02-02       Impact factor: 91.245

6.  Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients.

Authors:  Ilse Vanhorebeek; Rita De Vos; Dieter Mesotten; Pieter J Wouters; Christiane De Wolf-Peeters; Greet Van den Berghe
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

7.  Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.

Authors:  Greet Van den Berghe; Pieter J Wouters; Roger Bouillon; Frank Weekers; Charles Verwaest; Miet Schetz; Dirk Vlasselaers; Patrick Ferdinande; Peter Lauwers
Journal:  Crit Care Med       Date:  2003-02       Impact factor: 7.598

8.  Glucose control and mortality in critically ill patients.

Authors:  Simon J Finney; Cornelia Zekveld; Andi Elia; Timothy W Evans
Journal:  JAMA       Date:  2003-10-15       Impact factor: 56.272

9.  Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy.

Authors:  Dieter Mesotten; Johannes V Swinnen; Frank Vanderhoydonc; Pieter J Wouters; Greet Van den Berghe
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

10.  Effect of an intensive glucose management protocol on the mortality of critically ill adult patients.

Authors:  James Stephen Krinsley
Journal:  Mayo Clin Proc       Date:  2004-08       Impact factor: 7.616

View more
  18 in total

1.  Finding the sweet spot: identification of optimal glucose levels in critically injured patients.

Authors:  Matthew E Kutcher; Marci B Pepper; Diane Morabito; Dharma Sunjaya; M Margaret Knudson; Mitchell Jay Cohen
Journal:  J Trauma       Date:  2011-11

Review 2.  Metabolic consideration of epiphyseal growth: survival responses in a taxing environment.

Authors:  Irving M Shapiro; Vickram Srinivas
Journal:  Bone       Date:  2006-12-08       Impact factor: 4.398

3.  No, the glycaemic target in the critically ill should not be < or = 6.1 mmol/l.

Authors:  J M Miles; M M McMahon; W L Isley
Journal:  Diabetologia       Date:  2007-12-20       Impact factor: 10.122

4.  Parenteral glucose and glucose control in the critically ill: a kinetic appraisal.

Authors:  Roman Hovorka; Jeremy Cordingley
Journal:  J Diabetes Sci Technol       Date:  2007-05

5.  Analysis: New point-of-care blood glucose monitoring system for the hospital demonstrates satisfactory analytical accuracy using blood from critically ill patients--an important step toward improved blood glucose control in the hospital.

Authors:  Jeffrey I Joseph
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

6.  Evaluation of implementation of a fully automated algorithm (enhanced model predictive control) in an interacting infusion pump system for establishment of tight glycemic control in medical intensive care unit patients.

Authors:  Roman Kulnik; Johannes Plank; Christoph Pachler; Malgorzata E Wilinska; Andrea Groselj-Strele; Doris Röthlein; Matthias Wufka; Norman Kachel; Karl Heinz Smolle; Sabine Perl; Thomas Rudolf Pieber; Roman Hovorka; Martin Ellmerer
Journal:  J Diabetes Sci Technol       Date:  2008-11

7.  Multicenter Observational Study of the First-Generation Intravenous Blood Glucose Monitoring System in Hospitalized Patients.

Authors:  Grant V Bochicchio; Brian R Hipszer; Michelle F Magee; Richard M Bergenstal; Anthony P Furnary; Angela M Gulino; Michael J Higgins; Peter C Simpson; Jeffrey I Joseph
Journal:  J Diabetes Sci Technol       Date:  2015-06-01

8.  Evaluation of the VIA Blood Chemistry Monitor for Glucose in Healthy and Diabetic Volunteers.

Authors:  Arjunan Ganesh; Brian Hipszer; Navdeep Loomba; Barbara Simon; Marc C Torjman; Jeffrey Joseph
Journal:  J Diabetes Sci Technol       Date:  2008-03

9.  Tight glycaemic control by an automated algorithm with time-variant sampling in medical ICU patients.

Authors:  Christoph Pachler; Johannes Plank; Heinz Weinhandl; Ludovic J Chassin; Malgorzata E Wilinska; Roman Kulnik; Peter Kaufmann; Karl-Heinz Smolle; Ernst Pilger; Thomas R Pieber; Martin Ellmerer; Roman Hovorka
Journal:  Intensive Care Med       Date:  2008-02-23       Impact factor: 17.440

10.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

Authors:  Etie S Moghissi; Mary T Korytkowski; Monica DiNardo; Daniel Einhorn; Richard Hellman; Irl B Hirsch; Silvio E Inzucchi; Faramarz Ismail-Beigi; M Sue Kirkman; Guillermo E Umpierrez
Journal:  Diabetes Care       Date:  2009-05-08       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.